TJHA
BIIB icon

Thomas J. Herzfeld Advisors’s Biogen BIIB Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-100
Closed -$31K – 334
2015
Q4 		$31K Hold
100
– – 0.01% 239
2015
Q3 		$29K Hold
100
– – 0.01% 240
2015
Q2 		$40K Buy
+100
New +$40.1K 0.02% 192

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Thomas J. Herzfeld Advisors's BIIB Position: Q1 2016 in Review

Thomas J. Herzfeld Advisors sold out of Biogen (BIIB) in Q1 2016, closing a stake of 100 shares — an estimated $31K sold.

Thomas J. Herzfeld Advisors first reported a position in BIIB in Q2 2015 and held it in 3 quarters. The position peaked at $40K in Q2 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Thomas J. Herzfeld Advisors reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • Thomas J. Herzfeld Advisors sold 100 Biogen shares in Q1 2016, an estimated $31K.
  • Thomas J. Herzfeld Advisors first reported a position in Biogen in Q2 2015 and held it in 3 quarters.
  • Thomas J. Herzfeld Advisors's Biogen position peaked at $40K in Q2 2015.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q1 2016, filed 13 May 2016.